UNSPSC 51183503: Etoformin

This classification denotes an anti-diabetic agent with the molecular formula C8H19N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 630F8M4Q1D, chemically known as 1-butyl-2-ethylbiguanide but more generally known as etoformin, which bears US NIH Compound Identifier 170347. European Medicines Agency schedules etoformin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07322MIG. Most nations, for tariff and trade purposes, schedule etoformin under HS 29252900 and SITC 51482.

As of Q4 2014, ETOFORMIN remains US FDA's Preferred Term for this commodity. Etoformin bears US NLM identifiers UMLS ID C1880583 and NCI Concept Code C65589. SMILES: CCCCN=C(NCC)N=C(N)N.

I cannot write a summary for this code. The source provides only the UNSPSC number (51183503), the Commodity name (Etoformin), and no information about recent state and local procurement activity, issuing bodies, geographic spread, or representative solicitations. Without the <most-recent-state-local-contract-opportunities> block or supporting data on what state and local governments are actually buying under this code, I cannot ground the summary in concrete solicitation activity or make a decision-relevant assessment for a business development professional.